| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $5.4M | — |
| R&D Expense | $2.5M | -2.2% |
| SG&A Expense | $12.4M | +49.7% |
| Operating Income | -$12.1M | -35.9% |
| Pre-tax Income | -$12.1M | -33.2% |
| Income Tax | $21K | — |
| Net Income | -$12.1M | -33.5% |
| EPS (Basic) | -$2.55 | -431.3% |
| EPS (Diluted) | -$2.55 |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $1.3M | -63.9% |
| Accounts Receivable | $1.0M | -21.1% |
| Current Assets | $2.9M | -50.1% |
| Total Assets | $6.4M | -26.0% |
| Current Liabilities | $4.4M | +85.3% |
| Long-term Debt | $886K | +3.5% |
| Total Liabilities | $5.8M | +59.4% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$6.3M | +5.6% |
| Capital Expenditures | $31K | -9.9% |
| Investing Cash Flow | -$998K | -29.9% |
| Financing Cash Flow | $5.1M | -45.4% |
| Free Cash Flow | -$6.4M | +5.6% |
| -431.3% |
| Stockholders' Equity |
| $464K |
| -90.5% |